Joe Darrah

Philadelphia

Journalist at Freelance

Featured in: Favicon

hmpgloballearningnetwork.com Favicon

designnews.com Favicon

voiceamerica.com Favicon

mddionline.com Favicon

plasticstoday.com Favicon

advanceweb.com (+2) Favicon

packagingdigest.com Favicon

elitelearning.com Favicon

elitecme.com Favicon

innotechtoday.com + 4 more

Articles

FDA’s Power Play for Laboratory-Developed Tests Struck Down

2 days ago | mddionline.com | Joe Darrah

The once complicated future for laboratory-developed tests has been abandoned. But a fair amount of uncertainty remains. After nearly a year’s worth of trepidation about how laboratory-developed tests (LDTs) could be regulated, there appears to be no path for FDA to assume its oversight. As of May 30, the 60-day window for FDA to appeal a federal court’s decision that classifying LDTs as medical “devices” would exceed its statutory authority has passed.
Alerta para pacientes con enfermedad pulmonar crónica ante llegada de la temporada de alergias

3 days ago | espanol.medscape.com | Joe Darrah

El Dr. Michael A. Bernstein, neumólogo de Stamford Health, en Stamford, Estados Unidos, no puede contener su curiosidad cuando escucha la afirmación común: esta es la peor temporada de alergias de la historia. "Creo que siempre se dice que la temporada actual es 'la peor' para las alergias, pero es difícil saber lo mala que es cualquier temporada hasta que realmente termina".
Managing Comorbid Chronic Lung Disease With Allergies

2 weeks ago | medscape.com | Joe Darrah

Michael A. Bernstein, MD, can’t contain his curiosity when he hears the common claim: This is the worst allergy season ever. “I feel like the current season is always said to be ‘the worst’ for allergies, but it’s difficult to know how bad any season is until it’s actually over,” said Bernstein, a pulmonologist at Stamford Health, Stamford, Connecticut.
Addressing Medication Adherence Through Convenient Packaging

3 weeks ago | healthcarepackaging.com | Joe Darrah

Key Takeaways:· The American Heart Association estimates that more than half of medications prescribed today for patients living with chronic diseases are not taken as directed. · When enrolled in PillPack, customers receive monthly shipments of daily tear-away packets that are personalized and labeled with each medication (and its dosage).
Assessing the New Potential for a Congested Medtech Job Market

1 month ago | mddionline.com | Joe Darrah

Employment prospects for professionals in the medtech job market, and perhaps any type of role throughout the healthcare industry, are poised to be more difficult to ascertain this summer as the federal government continues to layoff thousands of agency workers through June.
Wearable Neuro Device Approved to Assist Rehab of Stroke & SCI

1 month ago | mddionline.com | Joe Darrah

Regardless of severity, recovery from stroke or spinal cord injury (SCI) is always a challenging process. This is especially true when the patient’s hands are affected.
Robotic-Assisted Procedures & Positive Outcomes Propel Market Expansion

2 months ago | mddionline.com | Joe Darrah

During what has been a rollercoaster-like pattern for more than a decade, market expectations for transcatheter mitral valve replacement (TMVR) devices are continuing to follow an upward trajectory in early 2025.
Developing Sound Strategies to Navigate the Tariff Turbulence

2 months ago | packagingdigest.com | Joe Darrah

White House Press Secretary Karoline Leavitt holds up a piece of paper with information about tariff rates while speaking during the daily briefing in the Brady Briefing Room of the White House in Washington, DC, on March 11, 2025. MANDEL NGAN via Getty ImagesAn unpredictable pattern of tariffs on imports kicked into a higher gear internationally this month, and the medtech industry is still trying to navigate an appropriate course in response.
Industry Pushback & Potential Impact on Diagnostic Testing

2 months ago | mddionline.com | Joe Darrah

As Donald Karcher, MD, FCAP, president of the College of American Pathologists (CAP) sees it, not all laboratory-developed tests (LDTs) are created equally. “There are clearly varying degrees of risk to these tests,” he told MD+DI. On the low-risk side of the spectrum are LDTs such as histochemical tests, which typically use dyes on skin cells and tissue to assist in disease diagnosis, and molecular tests that utilize polymerase chain reaction methodology to analyze blood, tissue, and urine.
Developing Sound Strategies to Navigate the Tariff Turbulence

2 months ago | mddionline.com | Joe Darrah

An unpredictable pattern of tariffs on imports kicked into a higher gear internationally this month, and the medtech industry is still trying to navigate an appropriate course in response. In the US, an unexpected improvement in the rate of inflation is presumed to be somewhat of a mirage with the most newly initiated tariffs set to increase the prices of goods across the global economy.